{
  "id": "5a9acba61d1251d03b000014",
  "type": "yesno",
  "question": "Has intepirdine been evaluated in clinical trials? (November 2017)",
  "ideal_answer": "Yes, intepirdine was in Phase III clinical trials in November 2017.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28720101"
  ],
  "snippets": [
    {
      "text": "Using small molecules blocking 5-HT6serotonin receptor (intepirdine), inhibiting BACE activity (E2609, AZD3293, and verubecestat), or reducing tau aggregation (TRx0237) are also currently in Phase III clinical trials.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28720101",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}